HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of Na+/Ca2+ Exchangers on Therapy Resistance of Ovary Carcinoma Cells.

AbstractBACKGROUND/AIMS:
According to previous observations, enhanced store-operated Ca2+-entry (SOCE) accomplished by the pore forming ion channel unit Orai1 and its regulator STIM1 contribute to therapy resistance of ovary carcinoma cells. Ca2+ signaling is further shaped by Ca2+ extrusion through K+-independent (NCX) and/or K+-dependent (NCKX) Na+/Ca2+-exchangers. The present study thus explored whether therapy resistance is further paralleled by altered expression and/or function of Na+/Ca2+-exchangers.
METHODS:
In therapy resistant (A2780cis) and therapy sensitive (A2780sens) ovary carcinoma cells transcript levels were estimated from RT-PCR, cytosolic Ca2+-activity ([Ca2+]i) from Fura-2-fluorescence, Na+/Ca2+-exchanger activity from the increase of [Ca2+]i (x0394;[Ca2+]i) and from whole cell current (Ica) following abrupt replacement of Na+ containing (130 mM) and Ca2+ free extracellular perfusate by Na+ free and Ca2+ containing (2 mM) extracellular perfusate, as well as cell death from PI -staining in flow cytometry.
RESULTS:
The transcript levels of NCX3, NCKX4, NCKX5, and NCKX6, slope and peak of x0394;[Ca2+]i as well as Ica were significantly higher in therapy resistant than in therapy sensitive ovary carcinoma cells. The Na+/Ca2+-exchanger inhibitor KB-R7943 (10 µM) significantly blunted x0394;[Ca2+]i and significantly augmented the cisplatin-induced cell death of therapy resistant ovary carcinoma cells without significantly modifying cisplatin-induced cell death of therapy sensitive ovary carcinoma cells.
CONCLUSION:
Enhanced Na+/Ca2+-exchanger activity may contribute to the therapy sensitivity of ovary carcinoma cells.
AuthorsLisann Pelzl, Zohreh Hosseinzadeh, Kousi Alzoubi, Tamer Al-Maghout, Sebastian Schmidt, Christos Stournaras, Florian Lang
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 37 Issue 5 Pg. 1857-68 ( 2015) ISSN: 1421-9778 [Electronic] Germany
PMID26584285 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Author(s) Published by S. Karger AG, Basel.
Chemical References
  • 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate
  • Ions
  • Protein Isoforms
  • Sodium-Calcium Exchanger
  • Thiourea
  • Cisplatin
  • Calcium
  • Fura-2
Topics
  • Apoptosis (drug effects)
  • Calcium (metabolism)
  • Cell Line, Tumor
  • Cisplatin (pharmacology, therapeutic use)
  • Drug Resistance, Neoplasm (genetics)
  • Female
  • Fura-2 (chemistry)
  • Humans
  • Ions (chemistry, metabolism)
  • Ovarian Neoplasms (drug therapy, metabolism, pathology)
  • Patch-Clamp Techniques
  • Protein Isoforms (antagonists & inhibitors, genetics, metabolism)
  • Real-Time Polymerase Chain Reaction
  • Sodium-Calcium Exchanger (antagonists & inhibitors, genetics, metabolism)
  • Thiourea (analogs & derivatives, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: